Inhibition of glioma using a novel non-neurotoxic vesicular stomatitis virus

13Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

OBJECTIVE The aim of this study was to demonstrate the in vivo safety and antitumor effect of a novel recombinant vesicular stomatitis virus (VSV): G protein less (GLESS)–fusion-associated small transmembrane (FAST)–VSV.

Cite

CITATION STYLE

APA

Jiang, B., Huang, D., He, W., Guo, W., Yin, X., Forsyth, P., … Wang, Z. (2021). Inhibition of glioma using a novel non-neurotoxic vesicular stomatitis virus. Neurosurgical Focus, 50(2), 1–8. https://doi.org/10.3171/2020.11.FOCUS20839

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free